Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| varenicline (CP-526,555) | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Continuous abstinence for the last 4 weeks of varenicline and NRT (Nicotine Replacement Therapy) treatment period |
| Measure | Description | Time Frame |
|---|---|---|
| Continuous abstinence last 4 weeks of treatment through Weeks 24 and 52 | ||
| 7-day point prevalence of abstinence: end of treatment, Weeks 24 and 52 | ||
| 4-week Point Prevalence of abstinence at Week 52 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Palo Alto | California | United States | |||
| Pfizer Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37142273 | Derived | Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8. | |
| 18263663 | Derived | Aubin HJ, Bobak A, Britton JR, Oncken C, Billing CB Jr, Gong J, Williams KE, Reeves KR. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax. 2008 Aug;63(8):717-24. doi: 10.1136/thx.2007.090647. Epub 2008 Feb 8. |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Long-Term Quit Rate at Weeks 24 and 52 |
| Minnesota Nicotine Withdrawal Scale |
| Smoking Effects Inventory |
| Santa Ana |
| California |
| United States |
| Pfizer Investigational Site | Farmington | Connecticut | United States |
| Pfizer Investigational Site | Lexington | Kentucky | United States |
| Pfizer Investigational Site | Worcester | Massachusetts | United States |
| Pfizer Investigational Site | Portland | Oregon | United States |
| Pfizer Investigational Site | Brussels | Belgium |
| Pfizer Investigational Site | Edegem | Belgium |
| Pfizer Investigational Site | Ghent | Belgium |
| Pfizer Investigational Site | Caen | France |
| Pfizer Investigational Site | Clermont-Ferrand | France |
| Pfizer Investigational Site | Limeil-Brévannes | France |
| Pfizer Investigational Site | Metz | France |
| Pfizer Investigational Site | Paris | France |
| Pfizer Investigational Site | Vandœuvre-lès-Nancy | France |
| Pfizer Investigational Site | Amsterdam | Netherlands |
| Pfizer Investigational Site | Enschede | Netherlands |
| Pfizer Investigational Site | Maastricht | Netherlands |
| Pfizer Investigational Site | Zutphen | Netherlands |
| Pfizer Investigational Site | London | Surrey | United Kingdom |
| Pfizer Investigational Site | London | United Kingdom |
| Pfizer Investigational Site | Nottingham | United Kingdom |
| ID | Term |
|---|---|
| D016540 | Smoking Cessation |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068580 | Varenicline |
| ID | Term |
|---|---|
| D001552 | Benzazepines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D011810 | Quinoxalines |
Not provided
Not provided